Sativex, a medical spray made from cannabis using equal parts THC and CBD, is effective in providing pain relief to those with multiple sclerosis, according to newly released research. “Delta-9-tetrahydrocannabinol (THC)/cannabidiol (CBD) (nabiximols or Sativex®) is an oromucosal spray formulation containing THC and CBD at an approximately 1:1 fixed ratio”, states the abstract of the …
A new study just released out of the U.K., and recently published in the Journal of Neurology, has examined the efficacy of the THC/CBD oromucosal spray Sativex on peripheral neuropathic pain (PNP). The peripheral nervous system connects nerves from the spinal cord and brain to the rest of the body; the pain associated with peripheral …
The National Health Service (NHS) in Wales has announced that it will be the first in the UK to distribute a cannabis-based medicine for the treatment of multiple sclerosis (MS). According to the NHS, Sativex, a cannabis-based medicine made of one part THC (tetrahydrocannabinol) and one part CBD (cannabidiol), will be available by prescription for …
Ireland’s Department of Health has announced that in the coming weeks it will introduce regulations which will allow for the use, possession and pharmacy-distribution of cannabis-based medicines such as Sativex, a medical spray made from the cannabis plant which contains one part THC (tetrahydrocannabinol) and one part CBD (cannabidiol). “This will be a prescription product, …
A study published last week by the journal European Neurology has found that the long-term use of Sativex, a spray made from the cannabis plant (one part THC, one part CBD), is effective in treating multiple sclerosis spasticity. According to researchers, the study’s objective was to “provide long-term data on clinical outcomes, tolerability, quality of life …
A new study published in this month’s issue of the journal European Neurology, and published online by the U.S. National Institute of Health, has found that Sativex – a medicinal spray made from the cannabis plant – is an effective and safe treatment option for “moderate to severe multiple sclerosis spasticity (MSS)”. According to researchers: …
France’s Ministry of Health announced today that the nation has officially approved the legalization of Sativex, a medicinal spray made from the cannabis plant. The approval of Sativex is the first cannabis-based medical product approved by France; in June, lawmakers approved legislation which allows the nation to accept cannabis medicines, with the National Security Agency …
In February we published an article titled 12 Things You Might Not Know About Cannabis. Here, we present the 2nd part to this article. The government-funded National Cancer Institute is forthright with the fact that cannabis has vast medical value, including tumor fighting capabilities. In drastic contrast to the Drug Enforcement Administration and other government entities, …
Switzerland has officially become the 23rd nation in the world to approve Sativex for use by those with multiple sclerosis; Sativex is a medical spray made up entirely of cannabis-derived cannabinoids. “This approval in Switzerland marks yet another regulatory success for Sativex, which is now approved in a total of 23 countries,” stated Justin Gover, …
